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Patients with chronic heart failure (CHF) exhibit orthopnea and tidal expiratory flow limitation in 
the supine position. It is unknown whether the flow limiting segment occurs in the peripheral or 
central part of the tracheobronchial tree. The location of the flow limiting segment can be inferred 
from the effects of heliox (80% He, 20% O2) administration. If maximal expiratory flow increases 
with this low density mixture, the choke point should be located in the central airways, where the 
wave-speed mechanism dominates. If the choke point were located in the peripheral airways, where 
maximal flow is limited by a viscous mechanism, heliox should have no effect on flow limitation 
and dynamic hyperinflation. 
Tidal expiratory flow limitation, dynamic hyperinflation and breathing pattern were assessed in 14 
stable CHF patients during air and heliox breathing at rest in sitting and supine position. 
No patient was flow limited in the sitting position. In the supine posture 8 patients exhibited tidal 
expiratory flow limitation on air. Heliox had no effect on flow limitation, dynamic hyperinflation 
and only minor effects on the breathing pattern. 
Lack of density dependence of maximal expiratory flow implies that in CHF patients the choke 









Tidal expiratory flow limitation (EFL) at rest has been detected in spontaneously breathing patients 
with acute heart failure both sitting and supine (1) and in patients with chronic heart failure (CHF) 
in the supine position only (2). At present it is not known whether in CHF the choke point is located 
in the central or peripheral part of the tracheobronchial tree. Such localization can be accomplished 
by studying the density dependence of maximal expiratory flow, and, consequently, the 
mechanisms by which tidal EFL develops. According to the wave-speed theory flow limitation 
results from the coupling between airway compliance and convective acceleration of gas (3). Since 
the pressure drop due to convective acceleration is density dependent, the wave-speed theory states 
that the maximal expiratory flow will increase with decreasing gas density. Flow limitation can also 
result from the coupling between airway compliance and viscous pressure losses (3). If flow is 
limited by this viscous mechanism, the maximal expiratory flow is not expected to change when gas 
density changes. When the maximal flow is limited at wave-speed (as is the case in normal subjects 
at high lung volume) the flow limiting segment is located in the central airways. In contrast, when 
the maximal flow is limited by a viscous mechanism (as is the case in normal subjects at low lung 
volume) the flow limiting segment is located in the peripheral airways (4). 
The aim of the present investigation is to assess whether the tidal EFL exhibited by CHF patients in 
the supine position is located centrally or peripherally. To this end the density dependence of EFL 
has been studied by replacing inspired air with heliox, a gas mixture three times less dense than air. 
The effect of heliox was assessed in terms of maximal expiratory flows, dynamic hyperinflation and 
breathing pattern, as previously described in patients with stable chronic obstructive pulmonary 
disease (5). 
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MATERIALS AND METHODS 
 
Fourteen stable ambulatory CHF patients (one woman) with a mean age of 57±3 (SE) years were 
studied. No patient had been hospitalized within the 20 days preceding the study. Heart failure was 
defined as symptomatic left ventricular dysfunction with a left ejection fraction of <0.45 
documented by bidimensional echocardiography. Congestive heart failure was post-ischemic in 9 
patients. No patient had peripheral edema. Three patients were current smokers, 3 non smokers and 
8 ex-smokers. At the time of the study 12 patients were being treated with diuretics, 8 with -
blockers and 4 with digoxin. On the experimental day, Weber class was determined by 
cardiopulmonary exercise testing (6): 3 patients were Weber class A (maximal oxygen uptake 




); 4 patients were Weber class B (V’O2max between 16 













). The predicted values of 
V’O2max were computed using Wasserman’s equations (7). Patients with primary pulmonary, 
neurologic or myopathic diseases were excluded. In particular, to avoid the possible confounding 
effects of subclinical chronic obstructive pulmonary disease, patients were also excluded if their 
FEV1/FVC was lower than 75% (8). To this end, before the beginning of the experiments, 
spirometry was performed with standard methods and procedures (9), using a mass flow sensor 
(Vmax 22; SensorMedics Co., Yorba Linda, CA, USA), reference values being those of the 
European Coal and Steel Community (9). The study was approved by the local ethical committee 
and each patient gave informed consent. 
The severity of chronic dyspnea was assessed with the modified Medical Research Council 
(mMRC) scale (10). 
Patients were investigated while breathing air and 10 minutes after equilibration with heliox. 
Measurements were carried out first seated and next supine (after 10 minutes of decubitus). Air and 
heliox breathing were performed in random order. 
The assessment of tidal EFL was done by means of the negative expiratory pressure (NEP) method 
(11). Subjects, wearing a noseclip, breathed quietly through a flanged mouthpiece, a heated 
pneumotachometer (3830A; Hans Rudolph; Kansas City, MO) connected to a differential pressure 
transducer (Celesco LCVR-0005; Raytech Instruments; Vancouver,
 
BC, Canada), and a low 
resistance two-way valve (2600; Hans Rudolph). The expiratory port of the valve was connected to 
a Venturi device and the inspiratory port to a shutter (RV-12, AeroMech Devices; Almonte, ON, 
Canada). The Venturi device was connected via a solenoid valve to a high pressure source and a 
regulator allowed for a preset pressure (-5 cmH2O) at the airway opening that was measured with a 
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pressure transducer (Celesco LCVR-0100; Raytech Instruments). The shutter was connected 
through a three-way stopcock to the ambient air or to a large plastic bag containing humidified 
heliox at ambient temperature. The patient was unaware of the gas mixture he was breathing. The 
pneumotachograph, calibrated with a 3 L syringe filled with the test gas, was linear over the 
experimental flow range. Pressure and flow signals were amplified, low-pass filtered at 50 Hz, and 
digitized at 100 Hz by a 16-bit AD converter (Direc Physiologic recording System; Raytech 
Instruments). Volume was obtained by numerical integration of the flow signal. The digitized data 
were stored on a computer and subsequently analyzed (LabVIEW Software; National Instruments; 
Austin, TX). 
In all cases several NEP tests were performed at intervals of 10 to 15 breaths, with the preceding 
expiration serving as control. The maneuvers were discarded if the superimposition between the 
inspiratory part of the flow-volume (V’-V) loop of control and test breath was poor. Patients were 
classified as non flow limited, if the application of NEP increased expiratory flow over the entire 
range of the control tidal volume (VT) (Fig. 1, panel A), or flow limited, if the control and test 
expiratory V’-V loops superimposed at least in part (Fig. 1, panel B). Two to three breaths after 
each NEP test, the subjects inspired to total lung capacity (TLC) for the assessment of inspiratory 
capacity (IC), and alignment of tidal V’-V curves with respect to TLC. IC was measured as the 
difference between TLC and the end-expiratory volume of the control breath, and used to assess 
changes in dynamic hyperinflation, an approach that has been shown to be reliable in COPD 
patients (12). In each patient and condition, a minimum of 4 acceptable IC maneuvers, and NEP 
applications were performed. 
Under all experimental conditions, 3 forced vital capacity (FVC) maneuvers were performed and 
the breathing pattern was assessed over a 3 minutes period. Dyspnea was measured in each 
experimental condition using a 100 mm visual analog scale (VAS). 
Data, presented as mean ± SE, were analyzed using a mixed between-within groups 
ANOVA. The correlation between mMRC score and routine spirometry measurements was 
examined using the non parametric Spearman rank correlation. Statistical significance was taken at 





Table 1 shows the anthropometric characteristics and baseline lung function of the patients in the 
sitting position. FVC, FEV1, expiratory reserve volume (ERV) and IC were reduced as compared to 
predicted values. In this posture none of the patients exhibited tidal EFL. Dyspnea at rest was 
modest, as indicated by the low value of the VAS score (12±2 mm). The significant correlation 
coefficients of mMRC vs the respiratory variables are shown in Table 2: mMRC correlated with IC 
(%pred), FVC (%pred) and FEV1 (%pred) (P=0.006, 0.009 and 0.038, respectively), as well as with 
age (P=0.042) and V’O2max (%pred) (P=0.001). 
Supine, air 
Shifting to the supine position caused the FVC to decrease (FVC=-0.20±0.04 L; P<0.01) and, as 
expected, IC to increase IC=0.42±0.09 L; P<0.01), while the breathing pattern remained 
unchanged. In this position, eight patients (57%) became flow limited. These patients had lower 
ERV than the non flow limited patients (0.25±0.04 L vs 0.49±0.10 L, respectively, P=0.02) (Table 3 
and Fig. 2). Dyspnea sensation tended to increase from sitting to supine position, but the increase 
was significant only in those patients who became flow limited (VAS 7±1, P<0.01). Because of 
the occurrence of tidal EFL in the supine position, anthropometric and spirometric data obtained in 
the sitting position were retrospectively reviewed in order to assess for any difference between 
patients who became or did not become flow limited (Table 1). The flow limited patients had 
significantly lower FVC than non flow limited patients (71±6 vs 92±4 %pred, P=0.02, respectively) 
and a higher BMI than the latter (30±1 vs 25±1 kg m-2, P<0.01, respectively). No difference was 
found in smoking history between the two groups of patients. In this regard, it is interesting that all 
the 3 non-smokers of this study became flow limited in the supine position. 
Effect of heliox 
In the sitting position heliox had no effect on IC. Table 3 shows the respiratory parameters in the 
supine position on air and heliox. Heliox did not abolish EFL in any instance, nor changed 
inspiratory capacity (Fig. 3). Heliox caused a modest reduction of inspiratory time (Ti=0.12±0.04 





The new finding of this study is that in all CHF patients who were flow limited while breathing air 
at rest, heliox had no effect on flow limitation and dynamic hyperinflation, assessed as a change in 
inspiratory capacity. Consequently in these patients tidal EFL arose from abnormalities within the 
peripheral part of the tracheobronchial tree, as it occurs in COPD patients at rest (5). 
Patient population 
Our patients exhibited a spirometric pattern compatible with restriction, since FVC, FEV1, ERV and 
IC were reduced, whereas FEV1/FVC ratio was normal. Several studies on CHF patients have 
documented a restrictive pattern of pulmonary impairment (2, 13), caused by an increase in vascular 
or interstitial lung water (14, 15), heart enlargement (13, 16) and a decrease in the force of the 
inspiratory muscles (17). 
Dyspnea sensation at rest (Table 1) in the sitting position was modest, as previously reported in 
stable CHF patients (2). Age and VO’2max were independent predictors of mMRC, the dependence 
on age could be related to the age-dependent impairment of the respiratory system (18). Because the 
mMRC scale measures the degree of breathlessness related to daily activities, it is not surprising 
that in our patients the best correlation of the mMRC score was with V’O2max (Table 2). The 
mMRC score was also closely correlated with IC (P=0.006). A reduction in IC can reflect an 
increase in functional residual capacity due to loss of lung recoil, as in COPD patients (5), or a 
decrease in total lung capacity because of an increased volume of non pulmonary intrathoracic 
structures, as in CHF patients (17). One may speculate that in the latter case the volume of the chest 
wall could be even increased, depending on the combined effect of the volumetric increase of non 
pulmonary intrathoracic structures and the decrease of lung compliance. In CHF patients, the 
inspiratory muscles, therefore, would work in a condition of mechanical disadvantage, increasing 
the dyspnea sensation, especially during exercise when dynamic hyperinflation may develop (19). 
Tidal flow limitation 
Tidal EFL was absent in all 14 CHF patients while breathing air in the sitting position. In contrast 8 
patients (57%) became flow limited when supine. One major factor involved in the development of 
tidal EFL in the supine position is the reduction of lung recoil secondary to the decrease of lung 
volume which occurs because of the expiratory action of the abdomen and shift of blood into the 
thoracic cavity. The changes in ERV occurring in our patients should closely reflect those in 
functional residual capacity, because changes in residual volume between the upright posture and 
recumbency are very small in normal subjects and residual volume in seated CHF patients is within 
normal limits (17; 20). In stable CHF patients the ERV can be reduced even in the sitting position 
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(Table 1), presumably because of the increased volume of the heart, blood vessels, and pulmonary 
interstitium (2; 13). As lung volume decreases, maximal expiratory flows decrease because of the 
decreased lung recoil, which is a major determinant of maximal flows. In CHF patients the decrease 
of maximal flows with decreasing lung volume is more prominent than in normal subjects: it has 
been shown in fact that maximal expiratory flows can be markedly reduced (65 %pred) in the lower 
25% of FVC without any substantial fall of FEV1 (92 %pred) (21). This could have occurred in our 
patients, because in the supine position flow limited patients had a lower ERV than non flow 
limited subjects (Table 3 and Fig. 2, upper panel), even when ERV was expressed in % of standing 
FVC (Fig. 2, lower panel). Moreover, our flow limited patients were overweight; this might have 
contributed  to the decrease of ERV as shown by a significant correlation between BMI and ERV 
(P=0.03), thus favoring the occurrence of EFL. Mild obesity by itself, however, cannot explain the 
high frequency of tidal EFL in supine CHF patients. Indeed, in a group of 16 healthy subjects with a 
BMI of 36±1 kg m-2 (range 30-40) we have found that only 3 exhibited EFL when supine, an 
incidence significantly lower than that of CHF patients (P<0.01). Moreover no EFL was observed 
in 9 normal, supine subjects with a BMI of 42±10 kg m
-2
 (22). 
Effects of heliox breathing 
In the absence of tidal EFL, no dynamic hyperinflation should be present and hence no change in IC 
should occur while breathing heliox. This was the case in 6 patients who were non flow limited in 
supine position and in all patients in the sitting posture. In the presence of EFL dynamic 
hyperinflation can develop, especially if the respiratory frequency is higher than normal, as it is 
usually the case in CHF patients (2, 23). Heliox may decrease dynamic hyperinflation by increasing 
the maximal expiratory flows if the choke point were located in the central airways and set by the 
wave-speed mechanism. In our 8 patients who were flow limited in the supine position heliox did 
not increase IC nor change the duration of expiration and the mean expiratory flow. This lack of 
density dependence of the expiratory flow indicates that the choke point is located in the peripheral 
airways, where the viscous mechanism dominates (3, 4). The location of the flow limiting segment 
in the peripheral airways implies modifications of their mechanical properties, namely an increase 
of resistance or compliance or both. Unfortunately there is no information about the functional state 
of the peripheral airways in CHF patients. When respiratory resistance was investigated with the 
forced oscillation technique, an enhanced frequency dependence of respiratory resistance has been 
detected (20, 24), a finding which is usually related to peripheral airways impairment. However, the 
fact that a similar frequency dependence has been found in patients with upper airway obstruction 
(25) makes this interpretation problematic. In seated CHF patients, total or pulmonary resistances is 
normal (23) or moderately elevated (20, 24). In contrast, in the supine position, the increase of 
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respiratory resistance is always greater than normal (20, 23). This suggests that the increase of 
respiratory resistance is due to the decrease of lung volume which takes place on switching from 
sitting to supine and/or vascular engorgement and interstitial edema, all factors which should 
mainly affect peripheral airways. In this connection, it should be noted that the effect of vascular 
engorgement and interstitial edema on peripheral resistance depends on pulmonary volume. Indeed, 
Ishii et al. (26) found that in open-chest dogs the increase in peripheral airway resistance with 
vascular engorgement, interstitial and alveolar edema was markedly reduced and eventually 
abolished by increasing lung volume. It seems likely that in at least some of our supine patients 
vascular engorgement was increased. In fact it has been shown (27) that in about 50% of CHF 
patients pulmonary capillary wedge pressure increases when switching from sitting to supine. On 
the other hand, studies performed in animal models have provided contrasting results: vascular 
engorgement and interstitial edema resulted in a decreased small airway cross section and 
presumably increased pulmonary resistance when airway caliber was measured with high resolution 
computed tomography (28) but not when it was assessed on histologic preparations (29). Although 
vagally mediated bronchocostriction might have also contributed to the increase of respiratory 
resistance in the supine position, it has been shown that administration of large doses of 
ipratropium, a muscarinic antagonist, to CHF patients attenuates the increase of pulmonary 
resistance only slightly (20). 
While breathing heliox, there was a significant reduction of dyspnea sensation and inspiratory 
duration, regardless of posture or EFL. However, these changes were very small and devoid of 
clinical significance. 
Whatever the precise nature of the tidal EFL exhibited by CHF patients in supine position, the 
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Legends for figures 
 
Figure 1. Example of a non flow limited (panel A) and of a flow limited (panel B) CHF patient 
breathing air in supine position. From top to bottom: time course of flow, volume (measured in 
litres from TLC) and mouth pressure with (second breath) and without NEP application. The 
bottom panel shows the corresponding flow-volume curves. 
Figure 2. Top panel: average expiratory reserve volume of 14 CHF patients breathing air sitting and 
supine stratified according to presence (n=8) or absence (n=6) of tidal EFL in supine position. All 
patients were not flow limited while sitting. Lower panel: as above, with the expiratory reserve 
volume expressed as % of FVC in sitting position. 
Figure 3. Top panel: mean values of IC during air and heliox breathing in 14 supine CHF patients. 
Bars are half ranges. Lower panel: relationship between IC in heliox and in air in 14 supine CHF 
patients. Dotted line: identity line. 
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Table 1. Anthropometric and routine lung function data of seated CHF patients breathing air 
stratified according to presence or absence of tidal EFL in the supine position 
 
 All  Flow limited  Non flow limited 
Subjects, No. 14    8    6    
Gender (M/F) 13/1    8/0    5/1    
Age, yr 57 ± 3  61 ± 3  51 ± 6  
Height, m 1.76 ± 0.01  1.78 ± 0.02  1.74 ± 0.02  
BMI, kg m
-2
 28 ± 1  30 ± 1*  25 ± 1  
mMRC 1.9 ± 0.3  2.3 ± 0.3  1.3 ± 0.4  
VAS, mm 12 ± 2  14 ± 2  8 ± 3  





 16.1 ± 1.5  14.4 ± 1.7  18.5 ± 2.7  





 11.9 ± 1.3  10.4 ± 1.1  13.8 ± 2.6  
FVC, %pred 80 ± 5  71 ± 6*  92 ± 4  
FEV1, %pred 72 ± 4  63 ± 4*  84 ± 4  
FEV1/FVC, %pred 94 ± 2  92 ± 2  95 ± 3  
IC, %pred 73 ± 5  66 ± 6  81 ± 6  
ERV, %pred 80 ± 10  65 ± 12  100 ± 14  
 
Values are mean ± SE. BMI: body mass index; mMRC: modified Medical Research Council score; 
VAS: Visual Analog Dyspnea score; V’O2max: maximal oxygen uptake; AT: anaerobic threshold; 
FVC: forced vital capacity; FEV1: forced expiratory volume in one second; IC: inspiratory capacity; 
ERV: expiratory reserve volume. 
*: significantly different from Non flow limited patients (P<0.05) 
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Table 2. Significant Spearman’s correlation coefficients of mMRC to various anthropometric 
and respiratory parameters in seated CHF patients 
 
 mMRC  
 rS P Value 
   
Age, years 0.548 0.042 
V’O2max, %pred -0.782 0.001 
FVC, %pred -0.665 0.009 
FEV1, %pred -0.559 0.038 
IC, %pred -0.693 0.006 
 
mMRC: modified Medical Research Council score; V’O2max: maximal oxygen uptake; FVC: 
forced vital capacity; FEV1: forced expiratory volume in one second; IC: inspiratory capacity. 
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Table 3. IC, ERV, VAS and breathing pattern during air and heliox breathing in the supine 
position in CHF patients stratified according to the presence or absence of tidal EFL 
 
   Flow limited  Non flow limited  
   air  heliox  air   heliox  
                   
No  8         6        
IC, L  2.68 ± 0.21  2.64 ± 0.20   3.11 ± 0.26  3.08 ± 0.27  
ERV, L  0.25 ± 0.05 * 0.26 ± 0.05 * 0.49 ± 0.10  0.57 ± 0.15  
Ti, s  1.47 ± 0.13  1.37 ± 0.11 † 1.58 ± 0.16  1.49 ± 0.19 † 
Te,s  1.95 ± 0.10  1.98 ± 0.14   2.06 ± 0.31  2.19 ± 0.39  
VT, L  0.70 ± 0.05  0.73 ± 0.06   0.65 ± 0.08  0.71 ± 0.13  
VT/Te, L/s  0.36 ± 0.03  0.38 ± 0.03   0.35 ± 0.05  0.36 ± 0.06  
VAS, mm  21 ± 3   19 ± 2 † 11 ± 4   9 ± 3 † 
 
Values are given as mean ± SE. 
IC: inspiratory capacity; ERV: expiratory reserve volume; VT: tidal volume; Ti: duration of 
inspiration; Te: duration of expiration; VT/Te: mean expiratory flow; VAS: Visual Analog Dyspnea 
score. 
*: significantly different from Non flow limited during air or heliox breathing (P<0.05) 
†: significantly different from air (P<0.05) 
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